FDAClass IISeptember 8, 2021

EL-Anti-SARS-CoV-2 IgG Kit recall

EL-Anti-SARS-CoV-2 IgG Kit, Catalog #104-130. Submitted as EUA202128

Why was EL-Anti-SARS-CoV-2 IgG Kit recalled?

The cross-reactivity of the device may present an increased level of potential false positives. Submitted as EUA202128

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot numbers 05204351, exp. 5/1/2021, and 05204368, exp. 05/19/2021.

Product
EL-Anti-SARS-CoV-2 IgG Kit, Catalog #104-130. Submitted as EUA202128
Recalling firm
Thera Test Laboratories, Inc.
Quantity
19 kits
Distribution
US Nationwide distribution in the states of California, Florida, Illinois, Indiana, North Carolina, and Texas.
Recall date
September 8, 2021
Classification
Class II
Status
Terminated
Agency
FDA (device)
Open FDA enforcement record Latest recalls